These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10096524)

  • 1. Impact of transfusions and acute rejection on posttransplantation donor antigen-specific responses in two study populations. Cooperative Clinical Trial in Transplantation Research Group.
    Reinsmoen NL; Matas AJ; Donaldson L; Carter S
    Transplantation; 1999 Mar; 67(5):697-702. PubMed ID: 10096524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity.
    Reinsmoen NL; Matas AJ
    Transplantation; 1993 May; 55(5):1017-23. PubMed ID: 7684534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
    Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
    J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
    Alexander JW; Light JA; Donaldson LA; Delmonico FL; Diethelm AG; Wilkinson A; Rosenthal JT; Thistlethwaite JR; Hunsicker LG; Matas AJ; First MR; Reinsmoen NL; Rose SM
    Transplantation; 1999 Oct; 68(8):1117-24. PubMed ID: 10551639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
    Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
    Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity.
    Reinsmoen NL; Hertz MI; Kubo SH; Bolman RM; Matas AJ
    Transplant Proc; 1994 Oct; 26(5):2558-9. PubMed ID: 7940790
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity.
    Jackson A; McSherry C; Butters K; Diko M; Almond PS; Matas AJ; Reinsmoen NL
    Hum Immunol; 1997 Jul; 55(2):148-53. PubMed ID: 9361966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
    Knight RJ; Kerman RH; Welsh M; Golden D; Schoenberg L; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):355-9. PubMed ID: 1994527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
    Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection.
    Reinsmoen NL; Cornett KM; Kloehn R; Burnette AD; McHugh L; Flewellen BK; Matas A; Savik K
    Transplantation; 2008 Feb; 85(3):462-70. PubMed ID: 18301338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
    Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stored blood--an effective immunosuppressive method for transplantation of kidneys from unrelated donors. An 11-year follow-up.
    Galvão MM; Peixinho ZF; Mendes NF; Sabbaga E
    Braz J Med Biol Res; 1997 Jun; 30(6):727-34. PubMed ID: 9292109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
    Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity.
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Matas AJ; Hertz MI
    J Heart Lung Transplant; 1994; 13(1 Pt 1):30-6; discussion 36-7. PubMed ID: 7513186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.